Results 211 to 220 of about 5,369,590 (244)

Dynamic drivers of carbon emission reduction in Lithuania under the European Green Deal: a wavelet analysis of synergies in waste management, energy efficiency, R&D, and international legal compliance. [PDF]

Carbon Balance Manag
Wen J, Eweade BS, Ozdeser H, Uzun B.
europepmc   +1 more source

R(D) and R(D*) at Belle

R(D) and R(D*) at Belle
openaire  

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Return on Investment (ROI) for Continuous Research and Development (R&D) Funding for Innovation-Driven Medical Research: From Knowledge to Policy. [PDF]

Biomed Res Int
Shahmy S, Fernando S, Abeyratne S, De Alwis A.   +3 more
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Does repetition equal more of the same? tie strength and thematic orientation in R&D networks. [PDF]

PLoS One
Yankova D, D'Este P, García-Melón M.
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source

Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D. [PDF]

Int J Mol Sci
Dubashynskaya NV, Petrova VA, Skorik YA.
europepmc   +1 more source

Retraction: Digital inclusive finance, R&D investment, and green technology innovation nexus. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China. [PDF]

Front Public Health
Li J, Zhang X, Wang R, Cao K, Wan L, Ren X, Ding J, Li W.   +7 more
europepmc   +1 more source